Hemophagocytic Syndrome: Report of 4 cases in Hospital Maria, Especialidades Pediátricas

Authors

DOI:

https://doi.org/10.5377/hp.v2i34.13573

Keywords:

hemophagocytic, fever, Epstein- Barr, steroids, etoposide

Abstract

Background: Hemophagocytic Syndrome (HS) is caused by an excessive or inadequate response of the immune system to a trigger or genetic deficiencies, which results in an exaggerated inflammatory reaction. It can be classified as primary if associated with hereditary factors or primary immunodeficiency's, or secondary, associated with infections, oncology or autoimmune diseases.

Description of clinical cases: in 2016, four cases regarding Hemophagocytic Syndrome were diagnosed at Hospital Maria, Especialidades Pediátricas. Three of them secondary to infections and one due to a oncology disease. Treatment of the four patients was based on the HLH-2004 protocol.

Conclusions: the objective is to make a timely diagnosis, start opportune treatment and thus reduce mortality percentage conferred by the Hemophagocytic Syndrome.

Abstract
255
PDF (Español (España)) 557

Author Biographies

María José Sarmiento, Hospital María, Especialidades Pediátricas

Pediatra, Servicio de Cardiología, Hospital María, Especialidades Pediátricas.

Karla Fernandez Zelaya, Hospital María, Especialidades Pediátricas

Inmuno-Alergóloga Pediatra, Directora HMEP, Hospital María, Especialidades Pediátricas.

Published

2021-12-28

How to Cite

Sarmiento, M. J. ., & Fernandez Zelaya, K. . (2021). Hemophagocytic Syndrome: Report of 4 cases in Hospital Maria, Especialidades Pediátricas. Honduras Pediátrica, 34(2), 18–23. https://doi.org/10.5377/hp.v2i34.13573

Issue

Section

Reporte de Casos